BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34634988)

  • 1. Angiotensin I-converting enzyme inhibitory peptide: an emerging candidate for vascular dysfunction therapy.
    Wu Q; Luo F; Wang XL; Lin Q; Liu GQ
    Crit Rev Biotechnol; 2022 Aug; 42(5):736-755. PubMed ID: 34634988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of the endogenous renin-angiotensin system in maintaining self-renewal and regeneration potential of epidermal stem cells.
    Liao X; Xiao J; Li SH; Xiao LL; Cheng B; Fu XB; Cui T; Liu HW
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2647-2656. PubMed ID: 31319155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
    Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
    Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
    J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
    Pernomian L; Pernomian L; Baraldi Araújo Restini C
    Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroacupuncture Improved Chronic Cerebral Hypoperfusion-Induced Anxiety-Like Behavior and Memory Impairments in Spontaneously Hypertensive Rats by Downregulating the ACE/Ang II/AT1R Axis and Upregulating the ACE2/Ang-(1-7)/MasR Axis.
    Feng P; Wu Z; Liu H; Shen Y; Yao X; Li X; Shen Z
    Neural Plast; 2020; 2020():9076042. PubMed ID: 32184813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
    Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis.
    Moreira FRC; de Oliveira TA; Ramos NE; Abreu MAD; Simões E Silva AC
    Mol Biol Rep; 2021 Sep; 48(9):6619-6629. PubMed ID: 34417705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology.
    Kehoe PG; Wong S; Al Mulhim N; Palmer LE; Miners JS
    Alzheimers Res Ther; 2016 Nov; 8(1):50. PubMed ID: 27884212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.
    Iwai M; Horiuchi M
    Hypertens Res; 2009 Jul; 32(7):533-6. PubMed ID: 19461648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
    Mori J; Zhang L; Oudit GY; Lopaschuk GD
    J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
    Lubel JS; Herath CB; Burrell LM; Angus PW
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1327-38. PubMed ID: 18557800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
    Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
    Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE and ACE2 in inflammation: a tale of two enzymes.
    Gaddam RR; Chambers S; Bhatia M
    Inflamm Allergy Drug Targets; 2014; 13(4):224-34. PubMed ID: 25019157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renin-angiotensin system on senescence.
    Mogi M
    Geriatr Gerontol Int; 2020 Jun; 20(6):520-525. PubMed ID: 32346971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
    Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
    Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical stretch/relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells.
    Becker BN; Yasuda T; Kondo S; Vaikunth S; Homma T; Harris RC
    Exp Nephrol; 1998; 6(1):57-66. PubMed ID: 9523174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of angiotensin converting enzyme (ACE)-like activity of acellular hemoglobin.
    Simoni J; Simoni G; Moeller JF; Tsikouris JP; Wesson DE
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(2):191-210. PubMed ID: 17453704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the AT1R/HIF-1 α /ACE axis mediates angiotensin II-induced VEGF synthesis in mesenchymal stem cells.
    Liu C; Zhang JW; Hu L; Song YC; Zhou L; Fan Y; Zhu HY; Wang Y; Li QP
    Biomed Res Int; 2014; 2014():627380. PubMed ID: 25401104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives for angiotensin profiling with liquid chromatography/mass spectrometry to evaluate ACE/ACE2 balance in endothelial dysfunction and vascular pathologies.
    Olkowicz M; Chlopicki S; Smolenski RT
    Pharmacol Rep; 2015 Aug; 67(4):778-85. PubMed ID: 26321281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.